Hardy Diagnostics Now Offers the BioCode® MDx-3000
14 mars 2022 07h00 HE
|
Hardy Diagnostics
SANTA MARIA, Calif., March 14, 2022 (GLOBE NEWSWIRE) -- Hardy Diagnostics, a leader in manufactured and distributed microbiology products, is pleased to announce it is now the exclusive distributor...
Sensor Patch Market Size to Reach USD 7.12 Billion by 2028 - Rising Demand for Portable Medical Devices & Wearable Sensors Drive the Market - Vantage Market Research
08 févr. 2022 07h04 HE
|
Vantage Market Research
WASHINGTON, Feb. 08, 2022 (GLOBE NEWSWIRE) -- The innovative Sensor Patch is a disposable, UHF, single-chip sensor inlay solution that offers cost efficiency, is easy to implement, and works on...
Brain Scientific Issues Shareholder Letter and Corporate Update
31 janv. 2022 08h00 HE
|
Brain Scientific Inc.
NEW YORK, Jan. 31, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific Inc. (OTCQB: BRSF), a leader in the medical technology market, today issues the following letter to shareholders from...
Sonic Incytes Medical Corp. Successfully Completes Series A Raise of US$7.3M to Accelerate Velacur™ Commercialization
07 déc. 2021 10h00 HE
|
Sonic Incytes Medical Corp.
VANCOUVER, British Columbia, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Sonic Incytes Medical Corp., a health technology company focused on liver health, is pleased to announce the completion of its US$7.3M...
Fluidigm to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
16 nov. 2021 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Global Allergy Diagnostic Market Expected to Generate a Revenue of $10,472.92 Million by 2028, Growing at a CAGR of 11.50% from 2021-2028 – Exclusive Report [180 Pages] By Research Dive
15 nov. 2021 09h00 HE
|
Research Dive
New York, USA, Nov. 15, 2021 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global allergy diagnostic market is expected to generate a revenue of $10,472.92 million by...
Velacur™ Data Presented at 2021 AASLD The Liver Meeting®
12 nov. 2021 08h00 HE
|
Sonic Incytes Medical Corp.
VANCOUVER, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Sonic Incytes Medical Corp. is pleased to announce that data from its sponsored clinical study of VelacurTM – the first handheld 3D liver health...
Talis Biomedical Granted FDA Emergency Use Authorization (EUA) for COVID-19 Molecular Point-of-Care Test to Detect SARS-CoV-2
08 nov. 2021 08h00 HE
|
Talis Biomedical Corporation
Authorized for use in a variety of healthcare and congregate settings, Talis One™ enables lab-quality results without the wait to detect or rule out COVID-19 in less than 30 minutes Talis One’s...
Fluidigm Announces Conference Call and Webcast of Third Quarter 2021 Financial Results
20 oct. 2021 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Sonic Incytes Showcases Velacur™ at ACG 2021
13 oct. 2021 10h00 HE
|
Sonic Incytes Medical Corp.
VANCOUVER, British Columbia, Oct. 13, 2021 (GLOBE NEWSWIRE) -- In recognition of Liver Awareness Month this October, Sonic Incytes Medical Corp. is pleased to showcase VelacurTM, the first handheld...